Skip to content 
Updated 14 October 2026: expanded with practical context and refreshed information. Original publication date retained.
Ivan Saltzman's founding role at Dis-Chem
Ivan and Lynette Saltzman founded Dis-Chem in 1978. Their contribution belongs to the development of a pharmacy-retail business that grew beyond its first store. Rui Morais became group CEO in July 2023, and Dis-Chem's July 2026 directorate announcement records Ivan Saltzman's departure as a non-executive director with effect from 23 July 2026.
These are different roles and dates. A founder's association can continue after executive responsibility changes, but a biography should not keep describing him as the current chief executive after a disclosed succession.
The business behind the retail range
Pharmacy retail connects professional services, a wider product assortment and distribution. The customer may see one shopping trip, while the operation manages buying, stock, staff and qualified pharmacy functions. Adding a branch increases those coordination requirements.
Publicly reported company results are useful for following later growth. Personal wealth cannot be calculated reliably by assigning all group assets or peak market values to the founder. Likewise, an unidentified colleague's description is not evidence of private hobbies, investments or leadership habits.
The useful business question is how the store proposition became a repeatable operation and how responsibilities passed to later leadership. That provides context for the founder's legacy without inventing a private financial portfolio.
Related reading from the original article
Dis-Chem's ownership · Dis-Chem's July 2026 directorate announcement · Botshilu Private Hospital · Checkers' CEO
From founder leadership to a listed retail system
Dis-Chem's investor results provide a more useful way to follow the business after Ivan Saltzman's founding period than an estimated personal fortune. Retail revenue, wholesale activity, operating profit and cash generated answer different questions. A larger turnover can coexist with pressure on margins or a greater amount of cash tied up in stock.
The operating model connects pharmacy services with a wider retail assortment and distribution infrastructure. That creates coordination work: a store needs the right range, stock availability and appropriately qualified people, while central buying and warehousing must support local demand. Centralisation brings scale but also requires reliable information between stores and suppliers.
For another retailer, the lesson is to make growth repeatable before opening more outlets. Document ordering, stock counts, staff responsibilities and the treatment of slow-selling products. A new branch adds rent and payroll immediately; its customer base and operating routines may take longer to mature.
Leadership succession is part of that system. Separate the founder's historical contribution from the responsibilities of the current chief executive and board. For a private business planning succession, decide who can approve spending, manage supplier relationships and access essential records, so that the operation does not depend on one person's memory.
Source and further reading: From founder leadership to a listed retail system — reference.
Additional sources: Dis-Chem: July 2026 directorate announcement.
